ARCHIVES

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.

September 29, 2000

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989